Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Whitehawk Therapeutics (WHWK) Restructuring Costs (2024)

Whitehawk Therapeutics (WHWK) has disclosed Restructuring Costs for 1 consecutive years, with $2.6 million as the latest value for Q3 2024.

  • On a quarterly basis, Restructuring Costs changed N/A to $2.6 million in Q3 2024 year-over-year; TTM through Sep 2025 was $2.6 million, a N/A change, with the full-year FY2024 number at $2.6 million, changed N/A from a year prior.
  • Restructuring Costs was $2.6 million for Q3 2024 at Whitehawk Therapeutics.
  • In the past five years, Restructuring Costs ranged from a high of $2.6 million in Q3 2024 to a low of $2.6 million in Q3 2024.